NCT05831631View on ClinicalTrials.gov

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

July 31, 2028

Study Completion Date

August 1, 2029

Conditions
Brain Tumor, PrimaryBrain Tumor - Metastatic
Interventions
DIAGNOSTIC_TEST

Circulating leukocytes immunophenotype

Blood samples will be tested with flow cytometry in order to characterize leukocyte subpopulations and to evaluate the circulating immunophenotype

DIAGNOSTIC_TEST

Tumor sampling

Immunohistochemical analysis will be performed on tumor samples in order to characterize immune T cells distribution within the tumor.

Trial Locations (1)

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors
lead

Pietro Mortini, MD, Prof.

OTHER